Rockwell Medical Inc. logo

Rockwell Medical Inc.

RMTI | NASDAQ
Chart Builder DCF Calculator
$8.69
-$0.01 (-0.11%)
Sep 22, 2026, 2:14 PM ET · Market open

Market Data

Market Cap
$34.34M
Enterprise Value
$24.26M
Beta
1.64
Average Volume
33.21K
Shares Outstanding (Diluted)
3.96M
Shares Change YoY
15.37%
Institutional Ownership
10.09%
Exchange
NASDAQ
ISIN
US7743744093

Price Performance

Price Change 1M
13.8%
Price Change 3M
33.2%
Price Change 6M
-14.4%
Price Change YTD
3.1%
Price Change 1Y
-32.1%
Price Change 3Y
-53.2%
Price Change 5Y
-87.5%
1M CAGR (ann.)
21.9%
1Y CAGR (ann.)
-34.6%
5Y CAGR (ann.)
-33.8%
All-Time CAGR
-20.3%

Valuation

PE Ratio
-6.40
Forward PE
N/A
PEG Ratio
0.03
Forward PEG
0.08
PS Ratio
0.51
Forward PS
0.40
PB Ratio
1.00
P/FCF Ratio
22.81
P/Adj. FCF Ratio
-106.13
P/OCF Ratio
12.19
EV/Sales
0.35
EV/EBIT
-6.14
EV/EBITDA
-10.37
EV/FCF
15.76
Earnings Yield
-15.6%
FCF Yield
4.4%
Adj. FCF Yield
-0.9%

Financial Health

Net Cash
$15.79M
Total Debt
$13.93M
Cash & Short-Term Investments
$24.8M
Total Assets
$56.53M
Current Ratio
3.25
Quick Ratio
3.00
Debt / Equity Ratio
0.40
Debt / EBITDA
-5.95
Debt / FCF
9.05
OCF / Debt
0.21
Interest Coverage
-3.99
Altman Z-Score
-7.56
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
17.7%
Operating Profit Margin
-6.5%
EBITDA Margin
-3.4%
Net Profit Margin
-7.3%
FCF Margin
2.2%
Adj. FCF Margin
-0.5%
SBC / Revenue
2.7%
SBC Impact (per share)
-121.5%

Returns

Return on Assets
-9.0%
Return on Equity
-14.0%
Return on Invested Capital
-9.2%
Return on Capital Employed
-10.0%
Return on Tangible Assets
-11.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
-2.9%
Revenue CAGR 5Y
2.6%
Revenue CAGR 10Y
2.2%
EPS CAGR 3Y
13.0%
EPS CAGR 5Y
78.6%
EPS CAGR 10Y
25.1%
FCF CAGR 3Y
1019.8%
FCF CAGR 5Y
95.2%
FCF CAGR 10Y
18.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
16
EPS Growth Next 3Y
66.9%
Revenue Growth Next 3Y
5.5%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.13
EPS Growth Est (next Q)
-74.0%
Revenue Est (next Q)
$18.22M
Revenue Growth Est (next Q)
14.4%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$20
Price Target Upside
124.7%

Cash Flow

Operating Cash Flow
$2.9M
Free Cash Flow
$1.54M
Adj. Free Cash Flow
$-331K
FCF Per Share
$0.39
OCF Per Share
$0.73
OCF/S Ratio
4.2%

Income Statement

Revenue
$69.39M
Gross Profit
$12.29M
Operating Income
$-4.52M
EBITDA
$-2.34M
Net Income
$-5.08M
EPS (Diluted)
-$1.39
Revenue / Employee
$441.97K
Profit / Employee
$-32.38K
Employees
157

© 2026 bestshares.com. All rights reserved.